Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256828
Status:
COMPLETED
Last Update Posted:
2007-10-16
First Post:
2005-11-21
Brief Title:
Once a Day QD - Twice a Day BID Clinical Trial Didanosine Lamivudine and Efavirenz Versus Zidovudine Lamivudine and Efavirenz in the Starting Treatment of HIV
Sponsor:
Organization:
Clinical Trial Agency of HIV Study Group
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
360
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: